Overview
Clinical trial sponsors and academia are facing a host of new registration requirements worldwide. With evolving requirements come new challenges, which call for benefits that create additional opportunities for knowledge-sharing and interaction with peers offer.
The 2022 Global Clinical Trial Disclosure and Data Transparency Conference builds on prior successful conferences to leverage learnings from regulators and international experts in the field. This event will provide essential, timely information about global clinical trial disclosure, data transparency, data sharing for secondary research, and the EU Clinical Trial Information System (CTIS) with the focus on transparency in relation to the protection of personal data and commercially confidential information. It brings leading study sponsors from industry and academia together with regulators and other players to exchange knowledge and share their experiences with the implementation of Clinical Trial Disclosure and Data Transparency from various viewpoints.
Featured
Want to learn more about Global Clinical Trial Disclosure & Data Transparency Conference? You've come to the right site!
Program Committee
-
Merete Joergensen, MBA, MSc Clinical Disclosure and Transparency Expert
Merete-J Consulting, Denmark -
Scott Feiner Senior Manager, Trial Disclosure
AbbVie, United States -
Robert Paarlberg, MS Principal
Paarlberg & Associates LLC, United States -
Matthias Zerm, PhD Lead Expert, Clinical Trial Disclosure and R&D Processes
Merz Therapeutics GmbH, Germany -
Thomas Schindler, PhD Director Global Regulatory Affairs - Regulatory Operations
BioNTech SE, Germany -
Joyce Swart Director, Clinical Trial Disclosure
Alcon Research, LLC, United States
Have an account?